Oryzon Genomics S.A.
ORY | MC
Overview
Corporate Details
- ISIN(s):
- ES0167733015
- LEI:
- 95980063R15RDF29DK13
- Country:
- Spain
- Address:
- Sant Ferran 74, 08940 Cornellà de Llobregat
- Website:
- https://www.oryzon.com/en
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Oryzon Genomics S.A. is a clinical-stage biopharmaceutical company and a European leader in the development of epigenetics-based therapeutics. The company discovers, develops, and plans to commercialize innovative, personalized medicines for diseases with high unmet medical needs. Utilizing its proprietary epigenetics platform, Oryzon focuses on two main therapeutic areas: oncology and central nervous system (CNS) disorders. The platform enables the identification and validation of biomarkers and therapeutic targets, translating them into advanced clinical programs.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Oryzon Genomics S.A..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 00:00 |
Post-Annual General Meeting Information
ORYZON anuncia los resultados de la votación de su Junta General Ordinaria de A…
|
Spanish | 44.3 KB | |
| 2025-05-26 08:04 |
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de accionistas de Oryzon Genomics, S…
|
Spanish | 139.0 KB | |
| 2025-05-26 00:00 |
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de accionistas de Oryzon Genomics, S…
|
Spanish | 139.0 KB | |
| 2025-05-12 07:52 |
Earnings Release
La sociedad remite información sobre los resultados del primer trimestre de 2025
|
Spanish | 370.8 KB | |
| 2025-05-08 08:06 |
Regulatory News Service
ORYZON recibe una ayuda no reembolsable de 13,26 millones de € para su proyecto…
|
Spanish | 250.1 KB | |
| 2025-04-29 00:00 |
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | |
| 2025-04-25 13:52 |
Declaration of Voting Results & Voting Rights Announcements
Se comunica la inscripción en el Registro mercantil de la escritura de ampliaci…
|
Spanish | 202.4 KB | |
| 2025-04-24 08:13 |
Share Issue/Capital Change
Resultado de la colocación acelerada
|
Spanish | 178.7 KB | |
| 2025-04-23 18:34 |
Share Issue/Capital Change
Lanzamiento de ampliación de capital acelerada
|
Spanish | 195.2 KB | |
| 2025-04-23 17:58 |
Share Issue/Capital Change
Lanzamiento de ampliación de capital acelerada
|
Spanish | 195.2 KB | |
| 2025-02-28 14:54 |
Post-Annual General Meeting Information
ORYZON anuncia los resultados de la votación de su Junta General Extraordinaria…
|
Spanish | 51.6 KB | |
| 2025-02-28 00:00 |
Post-Annual General Meeting Information
ORYZON anuncia los resultados de la votación de su Junta General Extraordinaria…
|
Spanish | 55.0 KB | |
| 2025-02-27 19:03 |
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
|
Spanish | 189.1 KB | |
| 2025-02-27 18:57 |
Governance Information
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
|
Spanish | 437.0 KB | |
| 2025-02-27 00:00 |
Annual Report
|
Spanish | 13.7 MB |
Automate Your Workflow. Get a real-time feed of all Oryzon Genomics S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oryzon Genomics S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
